Related Experiment Videos
Alpha heavy chain disease alpha mRNA contain nucleotide sequences of unknown origins
F Fakhfakh1, K Dellagi, H Ayadi
1Laboratory of Immunology, Faculty of Medicine, Sfax, Tunis, France.
Abstract:
Human alpha heavy chain disease is characterized by the production of abnormally short alpha IgH chains. In previously published cases it has been found that the malignant cells produce abnormal alpha mRNA, lacking VH and CH1 sequences and composed of a leader sequence peptide, sequences of variable length (69 to 84 bp) and of unknown origin, followed by normal CH2 and CH3 sequences. In this study we established the nucleotide sequence of alpha mRNA for six cases of alpha heavy chain disease. We observed that all six alpha mRNA lack the VH and CH1 sequences as do those previously described. They also contain in-frame inserts of unknown origin between the leader peptide and the normal CH2 and CH3 coding sequences. These inserts are of variable length (42 to 105 bp) and they are unrelated. These results suggest the existence of a common mechanism defect leading to deletions/insertions in alpha heavy chain disease rather than a specific interaction between alpha 1 IgH gene with a unique defined molecular species.
Insights
Human alpha heavy chain disease involves producing short alpha immunoglobulin heavy chains (IgH). This study found common nucleotide sequence defects in alpha mRNA, suggesting a shared molecular mechanism rather than specific gene interactions.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Human alpha heavy chain disease is defined by the synthesis of truncated alpha immunoglobulin heavy chains (IgH).
- Previously identified malignant cells in this disease produce abnormal alpha messenger RNA (mRNA) lacking variable (VH) and first constant (CH1) domains.
- This abnormal mRNA typically consists of a leader sequence, a variable-length insert of unknown origin, and normal CH2 and CH3 domains.
Purpose of the Study:
- To determine the nucleotide sequence of alpha mRNA in six distinct cases of human alpha heavy chain disease.
- To investigate the nature and origin of sequence variations within the abnormal alpha mRNA.
- To elucidate the underlying molecular mechanism responsible for the observed genetic alterations in alpha heavy chain disease.
Main Methods:
- Nucleotide sequencing of alpha mRNA was performed on samples from six patients with alpha heavy chain disease.
- Sequence analysis focused on identifying deletions, insertions, and variations in the mRNA structure.
- Comparative analysis was conducted with previously reported cases to identify common patterns.
Main Results:
- All six alpha mRNA sequences analyzed lacked the expected VH and CH1 domains, consistent with prior findings.
- In-frame inserts of variable lengths (42 to 105 base pairs) and unrelated sequences were identified between the leader peptide and the CH2/CH3 domains.
- These inserts were present in all studied cases, indicating a recurring molecular event.
Conclusions:
- The findings suggest a common underlying defect in alpha heavy chain disease pathogenesis.
- The observed deletions and insertions point towards a shared mechanism rather than a specific gene-molecule interaction.
- Further research is warranted to identify the precise molecular defect leading to these mRNA abnormalities.